Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitorsPenglie Zhang, Jingmei F Zuckett, John Woolfrey, et al.Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamidesZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activityPenglie Zhang, Liang Bao, Jingmei F Zuckett, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2004
1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 2: A survey of P4 motifsZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifsPenglie Zhang, Liang Bao, Jingmei F Zuckett, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2004
1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitorsZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Parallel synthesis and structure-activity relationships of a series of highly potent, selective, and neutral factor Xa inhibitorsShawn M Bauer, Erick A Goldman, Wenrong Huang, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Design, synthesis and structure-activity relationships of benzoxazinone-based factor Xa inhibitorsWenrong Huang, Penglie Zhang, Jingmei F Zuckett, et al.Journal of Medicinal Chemistry|May 1, 2009
A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora BIgnacio Aliagas-Martin, Dan Burdick, Laura Corson, et al.Journal of Medicinal Chemistry|October 12, 2011
Rational design of phosphoinositide 3-kinase α inhibitors that exhibit selectivity over the phosphoinositide 3-kinase β isoformTimothy P Heffron, Binqing Wei, Alan Olivero, et al.Pageof 4